Pharming Group N.V. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 66.7 million compared to USD 54.2 million a year ago. Revenue was USD 66.7 million compared to USD 54.2 million a year ago. Net income was USD 3.5 million compared to USD 9.1 million a year ago. Basic earnings per share from continuing operations was USD 0.005 compared to USD 0.014 a year ago. Diluted earnings per share from continuing operations was USD 0.005 compared to USD 0.013 a year ago.
For the nine months, sales was USD 164.1 million compared to USD 151 million a year ago. Net loss was USD 7.43 million compared to net income of USD 28.3 million a year ago. Basic loss per share from continuing operations was USD 0.011 compared to basic earnings per share from continuing operations of USD 0.043 a year ago. Diluted loss per share from continuing operations was USD 0.011 compared to diluted earnings per share from continuing operations of USD 0.04 a year ago.